PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation

Lucia Iannotta1,2, Marco Emanuele3, Giulia Favetta1

  • 1Department of Biology, University of Padova, Padua, Italy.

Insights

Leucine-rich repeat kinase 2 (LRRK2) phosphorylation is linked to Parkinson's disease. PAK6 kinase phosphorylates PPP2R2C, influencing its LRRK2 binding and localization, revealing a new regulatory mechanism for LRRK2 activity.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Neuroscience

Background:

  • Mutations in leucine-rich repeat kinase 2 (LRRK2) are a significant cause of Parkinson's disease (PD).
  • Dephosphorylation of LRRK2 at specific sites is implicated in PD pathogenesis.
  • Previous studies identified PP1, PP2A phosphatases, and PAK6 kinase as LRRK2 regulators.

Purpose of the Study:

  • To investigate a potential functional link between PAK6 kinase and LRRK2 phosphatases.
  • To elucidate the role of PAK6-mediated phosphorylation of the PP2A regulatory subunit PPP2R2C in LRRK2 regulation.

Main Methods:

  • PhosTag gel electrophoresis was employed using purified proteins.
  • Investigated the effect of PPP2R2C phosphorylation at S381 on PP2A holoenzyme formation and LRRK2 binding.
  • Assessed the impact of PAK6 kinase activity on PPP2R2C subcellular localization.
  • Evaluated the effect of PPP2R2C phosphorylation on PAK6-mediated LRRK2 dephosphorylation.

Main Results:

  • PAK6 phosphorylates PPP2R2C at serine 381 (S381).
  • S381 phosphorylation of PPP2R2C impairs its binding to LRRK2 but does not affect PP2A holoenzyme formation.
  • PAK6 kinase activity alters PPP2R2C subcellular localization in a manner dependent on S381 phosphorylation.
  • PAK6-mediated LRRK2 dephosphorylation is independent of PPP2R2C S381 phosphorylation, suggesting a dominant 14-3-3 mediated mechanism.

Conclusions:

  • PAK6-mediated phosphorylation of PPP2R2C influences its recruitment to LRRK2 and subcellular localization.
  • This finding reveals an additional layer of regulation in the fine-tuning of LRRK2 phosphorylation.
  • The study provides insights into the complex molecular mechanisms underlying Parkinson's disease.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K